PRKCD and adenocarcinoma: Loss of PKC-δ protein expression has been reported in human adenocarcinoma tissue (Craven and deRubertis, 1994) and this may underlie the reduced responsiveness of cancer tissue to the apoptosis-inducing effects of butyrate (Bonnotte et al, 1998).